Julie Priest

532 total citations
26 papers, 375 citations indexed

About

Julie Priest is a scholar working on Infectious Diseases, Epidemiology and Family Practice. According to data from OpenAlex, Julie Priest has authored 26 papers receiving a total of 375 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Infectious Diseases, 10 papers in Epidemiology and 6 papers in Family Practice. Recurrent topics in Julie Priest's work include HIV/AIDS Research and Interventions (14 papers), HIV/AIDS drug development and treatment (12 papers) and Medication Adherence and Compliance (6 papers). Julie Priest is often cited by papers focused on HIV/AIDS Research and Interventions (14 papers), HIV/AIDS drug development and treatment (12 papers) and Medication Adherence and Compliance (6 papers). Julie Priest collaborates with scholars based in United States, United Kingdom and Netherlands. Julie Priest's co-authors include C. Ron Cantrell, Kristina Yu-Isenberg, Steven Burch, Christopher L. Cook, MA Bonilla, David C. Dale, MH Freedman, Mark E. Weinblatt, Sharon Abish and Arnold Ganser and has published in prestigious journals such as Blood, Seminars in Arthritis and Rheumatism and Journal of Occupational and Environmental Medicine.

In The Last Decade

Julie Priest

24 papers receiving 362 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Julie Priest United States 12 77 72 70 62 56 26 375
José Luís Poveda-Andrés Spain 12 19 0.2× 86 1.2× 90 1.3× 130 2.1× 80 1.4× 52 457
Luz-Ma-Adriana Balderas-Peña Mexico 13 28 0.4× 16 0.2× 150 2.1× 129 2.1× 27 0.5× 41 630
Samir A. Haydar United States 10 22 0.3× 64 0.9× 75 1.1× 111 1.8× 6 0.1× 16 550
Liang Hua China 11 38 0.5× 25 0.3× 9 0.1× 18 0.3× 20 0.4× 24 345
G. Naheed Usmani United States 11 34 0.4× 9 0.1× 116 1.7× 23 0.4× 114 2.0× 15 578
Amy Morris United States 12 61 0.8× 7 0.1× 15 0.2× 112 1.8× 51 0.9× 31 470
Joel M. Hirsh United States 10 16 0.2× 31 0.4× 21 0.3× 37 0.6× 5 0.1× 19 355
Cindy Garris United States 16 9 0.1× 24 0.3× 109 1.6× 118 1.9× 351 6.3× 47 841
Betsy J. Lahue United States 10 22 0.3× 15 0.2× 48 0.7× 231 3.7× 316 5.6× 27 692
Eric M. Maiese United States 13 28 0.4× 5 0.1× 28 0.4× 60 1.0× 163 2.9× 43 580

Countries citing papers authored by Julie Priest

Since Specialization
Citations

This map shows the geographic impact of Julie Priest's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Julie Priest with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Julie Priest more than expected).

Fields of papers citing papers by Julie Priest

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Julie Priest. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Julie Priest. The network helps show where Julie Priest may publish in the future.

Co-authorship network of co-authors of Julie Priest

This figure shows the co-authorship network connecting the top 25 collaborators of Julie Priest. A scholar is included among the top collaborators of Julie Priest based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Julie Priest. Julie Priest is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Kumar, Princy, Amanda Clarke, Miguel García Deltoro, et al.. (2024). Patient-Reported Outcomes After Switching to a 2-Drug Regimen of Fixed-Dose Combination Dolutegravir/Lamivudine: 48-Week Results from the SALSA Study. AIDS and Behavior. 29(1). 235–245.
3.
4.
Priest, Julie, Rachel H. Bhak, Maral DerSarkissian, et al.. (2021). Retrospective analysis of adherence to HIV treatment and healthcare utilization in a commercially insured population. Journal of Medical Economics. 24(1). 1204–1211. 6 indexed citations
5.
Mills, Anthony, Kathy L. Schulman, Jennifer S Fusco, et al.. (2021). Virologic Outcomes Among People Living With Human Immunodeficiency Virus With High Pretherapy Viral Load Burden Initiating on Common Core Agents. Open Forum Infectious Diseases. 8(8). ofab363–ofab363. 3 indexed citations
6.
7.
Priest, Julie, et al.. (2019). Benchmarking HIV Quality Measures Across US Payer Types. Population Health Management. 23(2). 146–156. 5 indexed citations
8.
Priest, Julie, et al.. (2019). Clinical characteristics and treatment patterns among US patients with HIV.. PubMed. 25(12). 580–586. 4 indexed citations
9.
Mauskopf, Josephine, M. Fernandez, Jade Ghosn, et al.. (2019). 2510. Systematic Literature Review of Multiclass Resistance in Heavily Treatment Experienced Persons with HIV. Open Forum Infectious Diseases. 6(Supplement_2). S871–S871. 2 indexed citations
10.
Priest, Julie, et al.. (2018). Benchmarking HIV Quality Measures Across US Payer Types. Value in Health. 21. S159–S159. 1 indexed citations
11.
Drenkard, Cristina, Gaobin Bao, Tené T. Lewis, et al.. (2018). Physician–patient interactions in African American patients with systemic lupus erythematosus: Demographic characteristics and relationship with disease activity and depression. Seminars in Arthritis and Rheumatism. 48(4). 669–677. 27 indexed citations
12.
Priest, Julie, et al.. (2018). Benchmarking HIV Quality Measures in the US Opera HIV Cohort. Value in Health. 21. S159–S159. 1 indexed citations
13.
Lokhandwala, Tasneem, Robert Boggs, Anand A. Dalal, et al.. (2016). Prompt initiation of maintenance treatment following a COPD exacerbation: outcomes in a large insured population. International Journal of COPD. 11. 1223–1223. 8 indexed citations
14.
Krishnarajah, Girishanthy, Charlotte Carroll, Julie Priest, et al.. (2014). Burden of vaccine-preventable disease in adult Medicaid and commercially insured populations. Human Vaccines & Immunotherapeutics. 10(8). 2460–2467. 14 indexed citations
15.
Priest, Julie, C. Ron Cantrell, Jack E. Fincham, Christopher L. Cook, & Steven Burch. (2010). Quality of Care Associated with Common Chronic Diseases in a 9-State Medicaid Population Utilizing Claims Data: An Evaluation of Medication and Health Care Use and Costs. Population Health Management. 14(1). 43–54. 29 indexed citations
16.
Cantrell, C. Ron, Julie Priest, Christopher L. Cook, Jack E. Fincham, & Steven Burch. (2010). Adherence to Treatment Guidelines and Therapeutic Regimens: A US Claims-Based Benchmark of a Commercial Population. Population Health Management. 14(1). 33–41. 13 indexed citations
17.
Neugaard, Britta, Julie Priest, Steven Burch, C. Ron Cantrell, & Philip Foulis. (2010). Quality of Care for Veterans with Chronic Diseases: Performance on Quality Indicators, Medication Use and Adherence, and Health Care Utilization. Population Health Management. 14(2). 99–106. 25 indexed citations
18.
Nichol, Michael B., Tara K. Knight, Julie Priest, Joanne Wu, & C. Ron Cantrell. (2010). Nonadherence to clinical practice guidelines and medications for multiple chronic conditions in a California Medicaid population. Journal of the American Pharmacists Association. 50(4). 496–507. 22 indexed citations
19.
Yu-Isenberg, Kristina, et al.. (2008). The Effects of Health Plan Copayments on Adherence to Oral Diabetes Medication and Health Resource Utilization. Journal of Occupational and Environmental Medicine. 50(5). 535–541. 47 indexed citations
20.
Dale, David C., MH Freedman, MA Bonilla, et al.. (1995). Monosomy 7 and activating RAS mutations accompany malignant transformation in patients with congenital neutropenia. Blood. 86(12). 4579–4586. 107 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by José Luís Poveda-Andrés Breakdown of academic impact, for papers by Luz-Ma-Adriana Balderas-Peña Breakdown of academic impact, for papers by Samir A. Haydar Breakdown of academic impact, for papers by Liang Hua Breakdown of academic impact, for papers by G. Naheed Usmani Breakdown of academic impact, for papers by Amy Morris Breakdown of academic impact, for papers by Joel M. Hirsh Breakdown of academic impact, for papers by Cindy Garris Breakdown of academic impact, for papers by Betsy J. Lahue Breakdown of academic impact, for papers by Eric M. Maiese
Rankless by CCL
2026